DUBLIN--(BUSINESS WIRE)--The 'Gene Editing Therapeutics Market' report has been added to ResearchAndMarkets.com's offering.

都柏林--（商业新闻短讯）--“基因编辑疗法市场”报告已添加到ResearchAndMarkets.com的产品中。

The gene editing therapeutics market is estimated to be $11 million in 2024 and is forecasted to grow at a CAGR of 147% to reach a value of $1 billion by end of 2029.

2024年，基因编辑疗法市场估计为1100万美元，预计复合年增长率为147%，到2029年底将达到10亿美元。

Key factors driving market growth include:

推动市场增长的关键因素包括：

Increasing prevalence of chronic diseases

慢性病患病率上升

Increasing prevalence of rare and genetic disorders

罕见和遗传性疾病的患病率增加

Increasing strategic initiatives

增加战略举措

Need for precision medicine

精准医学的需求

This report highlights the current and future market potential of gene editing therapeutics and provides a detailed analysis of the drivers, restraints and opportunities in this market. It also surveys the competitive environment, including coverage of the pipeline activities adopted by market players, and it includes market projections for 2029..

本报告重点介绍了基因编辑疗法的当前和未来市场潜力，并详细分析了该市场的驱动因素，限制因素和机会。它还调查了竞争环境，包括市场参与者采用的管道活动的覆盖范围，并包括2029年的市场预测。。

Also included are company profiles of key players, featuring detailed information regarding each company's business segments, financials, product portfolios and recent developments.

还包括主要参与者的公司简介，其中包括有关每家公司的业务部门、财务状况、产品组合和最新发展的详细信息。

The Report Includes

该报告包括

15 data tables and 42 additional tables

15个数据表和42个附加表

An analysis of the current and future global markets for gene editing therapeutics

基因编辑疗法的当前和未来全球市场分析

Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029

全球市场趋势分析，包括2021-2023年的市场收入数据（销售数字），2024年的估计值以及到2029年的预计复合年增长率

Estimates of the market size and revenue forecasts for the global gene editing therapeutics market, with market share analysis by region

Discussion of the market dynamics, opportunities, and challenges, as well as emerging technologies

讨论市场动态、机遇和挑战以及新兴技术

Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes

行业可持续发展趋势和ESG发展概述，重点介绍领先公司的ESG实践、ESG排名和消费者态度

Competitive intelligence, including companies' market shares, recent M&A activity, and venture funding

竞争情报，包括公司的市场份额、最近的并购活动和风险投资

Company profiles of major players within the industry, including CRISPR Therapeutics, Vertex Pharmaceuticals, and Intellia Therapeutics

行业内主要参与者的公司简介，包括CRISPR Therapeutics，Vertex Pharmaceuticals和Intellia Therapeutics

Key Topics Covered:

涵盖的关键主题：

Chapter 1: Executive Summary

第一章：执行摘要

Chapter 2: Market Overview

第2章：市场概述

Genome-Editing Tool Types

基因组编辑工具类型

Meganucleases

大核酸酶

Zinc Finger Nucleases

锌指核酸酶

Transcription Activator-like Effector Nucleases

转录激活因子样效应核酸酶

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-Associated Protein 9

簇状规则间隔短回文重复序列（CRISPR）/CRISPR相关蛋白9

Gene editing Therapeutics

基因编辑疗法

Chapter 3: Market Dynamics

第3章：市场动态

Market Dynamics Snapshot

市场动态快照

Market Drivers

市场驱动因素

Increasing Prevalence of Chronic Disease

慢性病患病率增加

Increasing Prevalence of Rare Genetic Disorders

罕见遗传疾病的患病率增加

Precision Medicine

精准医学

Increasing Strategic Initiatives

增加战略举措

Market Restraints

Stringent Regulatory Frameworks and Time-Consuming Approval Processes

严格的监管框架和耗时的审批流程

High Cost of Treatment

治疗费用高

Adverse Events and Long-Term Monitoring

不良事件和长期监测

Lack of Skilled Workforce

缺乏熟练劳动力

Off-Target Impact

脱靶影响

Market Challenges

市场挑战

Patent Disputes

专利纠纷

Governmental Policies and Regulations

政府政策法规

Ethical Issues

道德问题

Market Opportunities

市场机会

Chapter 4: Emerging Technologies and Developments

第4章：新兴技术和发展

Base Editing

基本编辑

Prime Editing

主要编辑

Cas-Clover and Cas-FOKl

Cas三叶草和Cas FOKl

CRISPR Interference and CRISPR Activation

CRISPR干扰和CRISPR激活

RNA Editing

RNA编辑

Artificial Intelligence in Genome Editing

基因组编辑中的人工智能

Chapter 5: Pipeline Analysis

第5章：管道分析

Clinical Trial Analysis Based on Technology

基于技术的临床试验分析

Clinical Trial Analysis Based on Diseases

基于疾病的临床试验分析

Designations for Pipeline Drugs

管道药品名称

Chapter 6: Patent Analysis

第六章专利分析

Chapter 7: Market Analysis

Casgevy

卡斯格维

Market Overview

市场概况

Market Analysis

市场分析

Market by Region

按地区划分的市场

Chapter 8: Competitive Intelligence

第8章：竞争情报

Strategic Initiatives

战略举措

Competitive Landscape

竞争格局

Chapter 9: Sustainability in the Gene Editing Therapeutics Market: Environmental, Social and Governance (ESG) Perspectives

第9章：基因编辑治疗市场的可持续性：环境、社会和治理（ESG）观点

ESG Practices in the Gene Editing Companies

基因编辑公司的ESG实践

Companies Featured

公司特色

Allogene Therapeutics

异基因疗法

Beam Therapeutics

Beam治疗学

Caribou Biosciences Inc.

驯鹿生物科学公司。

CRISPR Therapeutics

CRISPR疗法

Editas Medicine

Editas医学

Intellia Therapeutics Inc.

Intellia Therapeutics公司。

Precision Biosciences

精密生物科学

Sangamo Therapeutics

Sangamo Therapeutics公司

Vertex Pharmaceuticals Inc.

Vertex制药公司。

Verve Therapeutics Inc.

Verve Therapeutics公司。

VOR Bio

VOR生物

For more information about this report visit https://www.researchandmarkets.com/r/x4lafn

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/x4lafn

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。